This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Broadridge (BR) Banking on Recurring Revenues, Debt Woe Stays
by Zacks Equity Research
Broadridge (BR) has a robust business model that ensures significant recurring-fee revenues. A debt-laden balance sheet is concerning.
FTI Consulting (FCN) Appoints New Senior MD in Latin America
by Zacks Equity Research
FTI Consulting (FCN) welcomes Gustavo Galizzi to the position of senior managing director in its Risk & Investigations practice within the Forensic and Litigation Consulting segment in Latin America.
S&P Global (SPGI) Stock Rises 25.5% in a Year: Here's Why
by Zacks Equity Research
S&P Global (SPGI) stock rides on consecutive better-than-expected top- and bottom-line performances, encouraging 2021 guidance and contributions from acquisitions.
Accenture (ACN) to Benefit From Linkbynet Buyout: Here's How
by Zacks Equity Research
The latest deal is expected to help Accenture (ACN) enhance its Accenture Cloud First capabilities, which will in turn aid clients' cloud migrations and business transformations.
Charles River (CRAI) Beats on Q1 Earnings, Ups '21 Guidance
by Zacks Equity Research
Charles River's (CRAI) first-quarter 2021 earnings and revenues improve year over year.
CRA International (CRAI) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CRA (CRAI) delivered earnings and revenue surprises of 65.06% and 13.88%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
CRAI vs. ACN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CRAI vs. ACN: Which Stock Is the Better Value Option?
Earnings Preview: CRA International (CRAI) Q1 Earnings Expected to Decline
by Zacks Equity Research
CRA (CRAI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CRA (CRAI) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
CRA (CRAI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Reasons Why You Should Hold on to Insperity (NSP) Stock
by Zacks Equity Research
Insperity (NSP) looks strong on the back of a growing professional employer organization industry.
WEX to Benefit from benefitexpress Acquisition: Here's How
by Zacks Equity Research
The latest deal is expected to help WEX strengthen its Health and Employee Benefit Solutions segment.
Charles River (CRAI) Announces Name of Marakon's New VP
by Zacks Equity Research
Charles River (CRAI) welcomes Miguel Maal to the position of vice president at its New York-based management consulting practice, Marakon.
Here's Why Investors Should Hold on to Verisk (VRSK) Stock
by Zacks Equity Research
Verisk (VRSK) is maintaining its focus on increasing solution penetration with customers and expanding into new sectors.
5 Reasons Why You Should Bet on CoreLogic (CLGX) Stock
by Zacks Equity Research
Acquisitions, over time, have helped CoreLogic (CLGX) increase its share in mortgage, real estate, insurance, capital markets, public sector and rental property markets.
Here's Why You Should Hold On to Rollins (ROL) Stock Now
by Zacks Equity Research
Organic revenue growth rate driven by strong technician and customer retention is aiding Rollins (ROL) stock. Meanwhile, escalating costs is a concern.
Accenture (ACN) Touches 52-Week High: What's Driving It?
by Zacks Equity Research
Encouraging yearly guidance and better-than-expected top- and bottom-line performances have been aiding Accenture's (ACN) stock.
5 Reasons to Add FTI Consulting (FCN) Stock to Your Portfolio
by Zacks Equity Research
FTI Consulting's (FCN) key business strengths include a broad range of practices and services, well-diversified revenue streams, and strong client relationships.
CRAI or ACN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRAI vs. ACN: Which Stock Is the Better Value Option?
FTI Consulting (FCN) Announces Name of New Senior MD in Australia
by Zacks Equity Research
FTI Consulting (FCN) welcomes Wynand Mullins to the position of senior managing director in its Forensic and Litigation Consulting segment in Australia.
Accenture (ACN) to Gain From Core Compete Buyout: Here's How
by Zacks Equity Research
The latest deal is expected to strengthen Accenture's (ACN) capabilities in analytics, data and AI space, globally.
S&P Global (SPGI) Introduces SPIVA Scorecard for MENA Region
by Zacks Equity Research
S&P Global's (SPGI) SPIVA MENA Scorecard tracks the performance of actively managed equity funds domiciled in the MENA region.
IQVIA Holdings (IQV) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
IQVIA Holdings (IQV) has been benefiting from consecutive better-than-expected top- and bottom-line performances, and encouraging yearly EPS guidance.
Ideanomics (IDEX) Selects Kristen Helsel as Chief Revenue Officer
by Zacks Equity Research
Helsel is responsible for driving growth, performance, strategy and alignment of Ideanomics' (IDEX) revenue-generating departments.
FactSet (FDS) and TSE to Cooperate for Thematic Index Creation
by Zacks Equity Research
To start with, FactSet (FDS) and TSE will cooperate to develop and promote prototype indices focused on the Japanese market.
IQVIA (IQV) Buys Remaining Q2 Solutions Stake, Ups EPS View
by Zacks Equity Research
The latest deal is expected to help IQVIA (IQV) strengthen its Research & Development Solutions segment.